Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
2023-06-01
Voluntary and Business Update Announcement New Drug Application of Tildrakizumab Injection Approved in China
2023-05-30
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
2023-05-04
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
2023-04-28
ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 APRIL 2023
2023-04-28
Voluntary and Business Update Announcement Ophthalmic Tetravalent Bispecific Antibody Product Being Granted an Approval for Drug Clinical Trial
2023-04-27
NOTIFICATION LETTER
2023-04-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
2023-04-06
NOTIFICATION LETTER
2023-04-06
FORM OF PROXY
2023-04-06